Purdue Pharma: $7.4B Opioid Settlement Reached
- A landmark $7.4 billion settlement has been reached with Purdue Pharma and the Sackler family, resolving litigation over the company's role in the opioid crisis.
- The agreement addresses lawsuits alleging that Purdue Pharma,under the Sackler family's leadership,aggressively marketed opioid products like OxyContin for decades,fueling addiction and overdose deaths across the nation.
- California, Colorado, connecticut, Delaware, Florida, Illinois, Massachusetts, Oregon, Pennsylvania, Tennessee, Texas, Vermont, Virginia, and West Virginia spearheaded negotiations for the settlement, the largest of its kind related to...
News Directory 3 reports a massive $7.4 billion opioid settlement reached, marking a turning point in the fight against the crisis. Purdue Pharma and the Sackler family agreed to the terms, resolving lawsuits over the company’s role in aggressively marketing opioid products like OxyContin. This historic settlement prohibits the Sacklers from future opioid-related activities. The funds will go towards crucial prevention, treatment, and recovery programs across the United States. Negotiations were spearheaded by several states, highlighting the widespread impact of the crisis. Pennsylvania Attorney General emphasized the importance of the settlement for his state. Discover what’s next regarding fund distribution and the ongoing efforts to combat the opioid epidemic.
States, Territories Reach $7.4B Purdue Pharma Opioid Settlement
A landmark $7.4 billion settlement has been reached with Purdue Pharma and the Sackler family, resolving litigation over the company’s role in the opioid crisis. All 50 states, Washington, D.C., and four U.S. territories have agreed to the terms.
The agreement addresses lawsuits alleging that Purdue Pharma,under the Sackler family’s leadership,aggressively marketed opioid products like OxyContin for decades,fueling addiction and overdose deaths across the nation. The historic opioid settlement ends the Sacklers’ ownership of Purdue and prohibits them from future opioid-related activities in the U.S.
California, Colorado, connecticut, Delaware, Florida, Illinois, Massachusetts, Oregon, Pennsylvania, Tennessee, Texas, Vermont, Virginia, and West Virginia spearheaded negotiations for the settlement, the largest of its kind related to the opioid crisis.
Pennsylvania Attorney General Dave Sunday emphasized the importance of the settlement for his state.
”As Pennsylvania families and communities suffered during an unprecedented addiction crisis, Purdue and the Sacklers reaped the mammoth profits from their products,” Sunday said. “This monumental settlement achieves the top priority of getting as much money as quickly as possible to prevention, treatment, and recovery programs across the Commonwealth. My office will continue engagement with municipal leaders to ensure millions of dollars reach every corner of the state.”
what’s next
The settlement funds are earmarked for prevention, treatment, and recovery programs to combat the ongoing opioid crisis across the United States. Further details on the distribution of funds are expected to be released in the coming months.